MODEL COLLABORATIVE RESEARCH AGREEMENTSCommercial Research Agreement • May 9th, 2023
of authorized representative), (hereinafter referred to as the “Institution”) which expression shall where the context so requires or admits, include its lawful representatives and assigns of the one part AND ………………………… (name of business) of (address) and
ContractCommercial Research Agreement • April 23rd, 2020
COMMERCIAL RESEARCH AGREEMENT CHECKLIST FOR INSTITUTIONAL REVIEW AND SIGNED SICRES, Faculty of Medicine Siriraj Hospital, Mahidol University
NEW BARD1 EXOSOME LIQUID BIOPSY PROJECTCommercial Research Agreement • November 29th, 2021
BARD1 has signed a Consultancy and Commercial Research Agreement with Griffith University to provide consultancy and scientific services to support the development and evaluation of an exosome-based BARD1 RNA test for detection of ovarian and breast cancers. The Agreement will be delivered through the experienced team at the Mucosal Immunology Research Group (MIRG) at Griffith University that has significant expertise in RNA analysis and profiling infection and inflammatory/immune responses. Plasma exosomes will be isolated using EXO-NET® at BARD1’s US-based facility and then transferred to Griffith University for analysis using custom-built Nanostring® expression assays.
COMMERCIAL RESEARCH AGREEMENTCommercial Research Agreement • November 8th, 2016 • South Australia
A The Parties have identified a particular commercial research and development activity as outlined in Item 3 of the Schedule (‘Project’) in which they desire to collaborate.
Central Adelaide Local Health NetworkCommercial Research Agreement • September 7th, 2020
Medicines Australia and Medical Technology Association of Australia Commercial Research Agreement - Standard Form Checklist
